Logo image of GBLT.CA

GBLT CORP (GBLT.CA) Stock Fundamental Analysis

TSX-V:GBLT - TSX Venture Exchange - CA36150R1029 - Common Stock - Currency: CAD

0.005  0 (0%)

Fundamental Rating

1

Overall GBLT gets a fundamental rating of 1 out of 10. We evaluated GBLT against 0 industry peers in the Unkown industry. Both the profitability and financial health of GBLT have multiple concerns. GBLT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GBLT had negative earnings in the past year.
GBLT had a positive operating cash flow in the past year.
In multiple years GBLT reported negative net income over the last 5 years.
In multiple years GBLT reported negative operating cash flow during the last 5 years.
GBLT.CA Yearly Net Income VS EBIT VS OCF VS FCFGBLT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 -1M -2M -3M -4M

1.2 Ratios

Industry RankSector Rank
ROA -12.37%
ROE N/A
ROIC N/A
ROA(3y)2.84%
ROA(5y)-14.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GBLT.CA Yearly ROA, ROE, ROICGBLT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 -500 -1K -1.5K -2K

1.3 Margins

GBLT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for GBLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.64%
GM growth 5YN/A
GBLT.CA Yearly Profit, Operating, Gross MarginsGBLT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

GBLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
GBLT has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for GBLT has been reduced compared to a year ago.
GBLT.CA Yearly Shares OutstandingGBLT.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
GBLT.CA Yearly Total Debt VS Total AssetsGBLT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2M 4M 6M

2.2 Solvency

Based on the Altman-Z score of 1.04, we must say that GBLT is in the distress zone and has some risk of bankruptcy.
GBLT has a debt to FCF ratio of 2.72. This is a good value and a sign of high solvency as GBLT would need 2.72 years to pay back of all of its debts.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.72
Altman-Z 1.04
ROIC/WACCN/A
WACC1.41%
GBLT.CA Yearly LT Debt VS Equity VS FCFGBLT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 500K -500K -1M -1.5M -2M

2.3 Liquidity

A Current Ratio of 0.88 indicates that GBLT may have some problems paying its short term obligations.
A Quick Ratio of 0.50 indicates that GBLT may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.5
GBLT.CA Yearly Current Assets VS Current LiabilitesGBLT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2M 4M 6M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for GBLT have decreased strongly by -1172.73% in the last year.
GBLT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.92%.
The Revenue has been growing by 24.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1172.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%278.95%
Revenue 1Y (TTM)-35.92%
Revenue growth 3Y24.8%
Revenue growth 5YN/A
Sales Q2Q%-39.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GBLT.CA Yearly Revenue VS EstimatesGBLT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 10M 20M 30M
GBLT.CA Yearly EPS VS EstimatesGBLT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GBLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GBLT.CA Price Earnings VS Forward Price EarningsGBLT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 0.39
EV/EBITDA N/A
GBLT.CA Per share dataGBLT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GBLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GBLT CORP

TSX-V:GBLT (5/6/2024, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-16 2024-05-16
Earnings (Next)08-27 2024-08-27
Inst Owners0%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap566.64K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 0.39
P/OCF 0.36
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY258.63%
OCF(TTM)0.01
OCFY280.45%
SpS0.33
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.37%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.76%
FCFM 3.9%
ROA(3y)2.84%
ROA(5y)-14.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1603.17%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.64%
GM growth 5YN/A
F-Score4
Asset Turnover2.94
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.72
Debt/EBITDA N/A
Cap/Depr 65.6%
Cap/Sales 0.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.5
Altman-Z 1.04
F-Score4
WACC1.41%
ROIC/WACCN/A
Cap/Depr(3y)66.62%
Cap/Depr(5y)52.6%
Cap/Sales(3y)0.17%
Cap/Sales(5y)0.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1172.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%278.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.92%
Revenue growth 3Y24.8%
Revenue growth 5YN/A
Sales Q2Q%-39.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-340.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y173.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.15%
OCF growth 3YN/A
OCF growth 5YN/A